|
PF-52201 |
NUWIQ 1000 UI Polvo y solución para uso parenteral |
2025-12-01 |
|
Octapharma AB |
Suecia
|
Agefinsa |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
PF-52202 |
NUWIQ 500 UI Polvo y solución para uso parenteral |
2025-12-01 |
|
Octapharma AB |
Suecia
|
Agefinsa |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
PF-52204 |
NUWIQ 250 UI Polvo y solución para uso parenteral |
2025-12-01 |
|
Octapharma AB |
Suecia
|
Asistencia Respiratoria |
Servicios Quirúrgicos |
Agefinsa |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
PF-49169 |
OCTAGAM 10% Solución inyectable |
2028-01-09 |
|
Octapharma AB |
Suecia
|
Agefinsa (Agencia Farm. Intern., S.A.) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
PF-49248 |
OCTANATE 100 UI/ml Polvo liofilizado y solución para uso parenteral |
2028-08-09 |
|
Octapharma AG |
Suecia
|
Agefinsa |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
PF-49467 |
OCTANATE 50 UI/mL Polvo Liofilizado y solución para uso parenteral |
2028-11-23 |
|
Octapharma AG |
Suecia
|
Agefinsa |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
PF-49864 |
GAMMANORM 165 mg/ml Solución inyectable |
2024-04-02 |
|
Octapharma AB |
Suecia
|
Agefinsa |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
PF-52092 |
WILATE 100 UI/mL Polvo y solución para uso parenteral |
2025-11-03 |
|
Octapharma Pharmazeutika Produktionsgesellschaft M.b.H. |
Austria
|
Agefinsa |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
PF-60487 |
FIBRYGA 1 g Polvo liofilizado y solución para uso parenteral |
2026-12-22 |
|
Octapharma AG |
Austria
|
Agefinsa |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
PF-34731 |
ALBUMINA HUMANA Octapharma 5% solucion inyectable |
2015-01-20 |
|
Octapharma Pharmazeutika Produktionsgesellschaft M.b.H. |
Austria
|
Agefinsa (Agencia Farm. Intern., S.A.) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|